Your browser doesn't support javascript.
loading
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours.
Rizzo, Francesca M; Vesely, Clare; Childs, Alexa; Marafioti, Teresa; Khan, Mohid S; Mandair, Dalvinder; Cives, Mauro; Ensell, Leah; Lowe, Helen; Akarca, Ayse U; Luong, TuVinh; Caplin, Martyn; Toumpanakis, Christos; Krell, Daniel; Thirlwell, Christina; Silvestris, Franco; Hartley, John A; Meyer, Tim.
Afiliação
  • Rizzo FM; Department of Oncology, UCL Cancer Institute, University College London, London, UK.
  • Vesely C; Department of Oncology, UCL Cancer Institute, University College London, London, UK.
  • Childs A; Department of Oncology, UCL Cancer Institute, University College London, London, UK.
  • Marafioti T; Department of Pathology, UCL Cancer Institute, University College London, London, UK.
  • Khan MS; Wales Neuroendocrine Tumour Service, Department of Gastroenterology, University Hospital of Wales, Cardiff, UK.
  • Mandair D; Neuroendocrine Tumour Unit, Department of Gastroenterology, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust, London, UK.
  • Cives M; Department of Biomedical Sciences and Human Oncology, University of Bari "A. Moro", Bari, Italy.
  • Ensell L; Department of Oncology, UCL Cancer Institute, University College London, London, UK.
  • Lowe H; Department of Oncology, UCL Cancer Institute, University College London, London, UK.
  • Akarca AU; Department of Pathology, UCL Cancer Institute, University College London, London, UK.
  • Luong T; Department of Histopathology, Royal Free London NHS Foundation Trust, London, UK.
  • Caplin M; Neuroendocrine Tumour Unit, Department of Gastroenterology, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust, London, UK.
  • Toumpanakis C; Neuroendocrine Tumour Unit, Department of Gastroenterology, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust, London, UK.
  • Krell D; Neuroendocrine Tumour Unit, Department of Oncology, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust, London, UK.
  • Thirlwell C; Department of Oncology, UCL Cancer Institute, University College London, London, UK.
  • Silvestris F; Neuroendocrine Tumour Unit, Department of Oncology, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust, London, UK.
  • Hartley JA; Department of Biomedical Sciences and Human Oncology, University of Bari "A. Moro", Bari, Italy.
  • Meyer T; Department of Oncology, UCL Cancer Institute, University College London, London, UK.
Br J Cancer ; 120(3): 294-300, 2019 02.
Article em En | MEDLINE | ID: mdl-30636773
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Tumores Neuroendócrinos / Receptores CXCR4 / Células Neoplásicas Circulantes Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Tumores Neuroendócrinos / Receptores CXCR4 / Células Neoplásicas Circulantes Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido